Related Experiment Videos

Purification of the inducible nitric oxide synthase

¹Glaxo Wellcome, Research Triangle Park, NC, USA.

Methods in Molecular Biology (Clifton, N.J.)

|July 25, 2000

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The novel fungal CYP51 inhibitor VT-1598 displays classic dose-dependent antifungal activity in murine models of invasive aspergillosis.

Medical mycology·2020

The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis.

The Journal of antimicrobial chemotherapy·2018

Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds.

Antimicrobial agents and chemotherapy·2016

Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis.

Antimicrobial agents and chemotherapy·2015

VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model.

Antimicrobial agents and chemotherapy·2015

The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme.

Antimicrobial agents and chemotherapy·2014

See all related articles